The Japanese Journal of Urology
Online ISSN : 1884-7110
Print ISSN : 0021-5287
URINARY HYDROXYPROLINE EXCRETION AS A MARKER OF BONE METASTASIS IN PROSTATIC CANCER (II)
Correlation Between Extent of Metastatic Lesions in Whole Body Bone Scintigraphy of Patients with Prostatic Cancer and Tumor Markers in Blood and Urine
Shin-ichi NemotoKenji Rinsho
Author information
JOURNAL FREE ACCESS

1984 Volume 75 Issue 1 Pages 53-58

Details
Abstract

In 25 patients with prostatic cancer confirmed histologically, 24 patients had bone metastasis on the whole body bone scintigraphy. The extent of bone metastasis was estimated quantitatively by the computerized digitizer. At the same time, the number of the metastatic lesions was counted. The correlations between the area of metastatic lesions on the 99mTc-MDP bone scintigrams and ESR, LDH, total acid phosphatase, prostatic acid phosphatase, ALP and urinary hydroxyproline/creatinine levels were further investigated. The number of the metastatic lesions was also investigated with the same tumor markers. The results are as follows:
1) The extent of the metastatic lesions was showed more accurately by the area measured with the computerized digitalizer than by the number of metastatic lesions.
2) The correlation between the area of metastatic lesions and serum ALP levels was relatively high (γ=0.75). But almost all were within normal limits.
3) As for the relation between the area of the metastatic lesions and the urinary hydroxyproline/creatinine levels, the correlation was high (γ=0.78). And the hydroxyproline/creatinine levels were almost over the upper limit. Therefore, the urinary hydroxyproline/creatinine was considered as a good marker of the extent of bone metastasis.

Content from these authors
© Japanese Urological Association
Previous article Next article
feedback
Top